Učitavanje...
Trastuzumab
Trastuzumab is standard of care in the treatment of human epidermal growth factor receptor (HER)-2(+) early and advanced breast cancer. Recently, it has been approved for the treatment of HER-2(+) advanced gastric cancer. Trastuzumab is an IgG1 humanized monoclonal antibody administered by intraveno...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228213/ https://ncbi.nlm.nih.gov/pubmed/21632460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0035 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|